The departure of Hipgnosis Song Management (HSM) founder Merck Mercuriadis is unlikely to have any major implications for Hipgnosis Songs fund (SONG) shareholders, analysts have argued.
HSM, the investment manager of SONG, said on Tuesday (2 July) that the former chief executive and founder of the company would be stepping out as chair once the takeover deal by private equity giant Blackstone is completed. Matthew Read, senior analyst at QuotedData, said the announcement about Mercuriadis' future plans has "zero bearing" on SONG shareholders, as it made no change to the Blackstone deal. "The portfolio is being sold and this latest announcement from HSM does not change that, or the price that is being paid," he added. Merck Mercuriadis to step down as chair of Hi...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
